After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
Shares Stats
| Shares Outstanding | 16,850,000 |
| Shares Float | 16,850,000 |
| Shares Short | 500,000 |
| Insider Holdings | 0% |
| Institution Holdings | 1.88% |
About Aptevo Therapeutics Inc
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
General
| Name | Aptevo Therapeutics Inc |
| Ticker | APVO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 37 |
Highlights
| Analyst Target | 21.00 |
| Market Cap | 24,400,000 |
| EBITDA | -26,468,000 |
Financials
| Curr Year EPS Estimate | -5.38 |
| Next Quarter EPS Estimate | -1.90 |
| Return on Assets | -0.79 |
| Return on Equity | -2.43 |
| Earnings Per Share | 1,950.74 |
| Gross Profit | 345,000 |
| Quarterly Revenue Growth | -1 |
Valuation
| Trailing PE | 0.00 |
| Forward PE | 3.94 |
| Price/Sales (Trailing 12 Mt.) | 1.61 |
| Price/Book (Most Recent Quarter) | 1.42 |
Earnings
Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low
Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.
AT&T reached a $177M data breach settlement. What consumers should know about claiming their money
NEW YORK (AP) — AT&T has reached a combined $177 million settlement over two . And impacted consumers have a little over a month left to file a claim for their chunk of the money.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
SharpLink Gaming (SBET) Q3 2025 Earnings Call Transcript
SharpLink Gaming reported third-quarter financial results on Thursday. The transcript from the earnings call has been provided below.
Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker
On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
Why a Visa-Mastercard legal settlement could lead to your rewards credit card getting declined
NEW YORK (AP) — Visa and Mastercard have proposed a settlement in their long-running legal dispute with merchants and retailers over how much they charge merchants to accept their cards.
Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It
November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Cathie Wood Goes Big On Alibaba With $25 Million Share Purchase, Scales Back On This Social Media Stock
Ark Invest made big moves in its portfolio, focusing on Alibaba, Baidu, and Reddit amid evolving market dynamics and regulatory challenges.
From beaches to ski slopes, photos show how cameras keep watch all over China
BEIJING, China (AP) —
Why Wall Street Is Piling Into the "Debasement Trade" - Ad
Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.
Trump's White House Bathroom Renovation Sparks Fury, Economist Slams 'Clearly Wrong' Inflation Data And More: This Week In Economy
Week economy roundup: From inflation debates and White House renovations to job declines, stock surges, and Fed rate cuts.
Ford's Recall Count Climbs To 134 In 2025 — CEO Jim Farley Sees It As Biggest 'Near-Term Opportunity'
Ford has been plagued by recalls, tariffs, and quality control issues, with CEO Jim Farley optimistic about addressing them.
Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad
Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are
Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Denny's to be acquired and taken private in a deal valued at $620 million
Denny's said Monday that it's being acquired by a group on investors in a deal that will take the breakfast chain private.
Nvidia has started the $5 trillion club. A look at its rise, by the numbers
Nvidia on Wednesday became the first public company to reach .
AI Meets Real-World Security with the K7 - Ad
Continuous patrols. Instant response. Zero fatigue. The K7 merges robotics and data to outperform humans in coverage, cost, and consistency and it's already live across the US.
Visa Q3 Preview: Could Credit Card Stock Be 'Poised To Snap Back To Its Winning Ways?'
Visa looks to piggyback off a strong earnings report from American Express and show strength in consumer spending.
Attackers board a ship off the coast of Somalia after firing rocket-propelled grenades
DUBAI, United Arab Emirates (AP) — Attackers firing machine guns and rocket-propelled grenades boarded a ship off the coast of on Thursday, British officials said, likely the latest assault by resurgent Somali pirates operating in the region.
You're Almost Out of Time to Place This "Debasement Trade" - Ad
Wall Street has been making headlines for piling into a strange new money move they're calling the "Debasement Trade"... And it could affect you and your money in a MAJOR way. According to Dr. David Eifrig the clock is ticking for you to get your money in the right place.
Nigerian billionaire plans expansion of Africa's biggest oil refinery
ABUJA, Nigeria (AP) — The billionaire owner of plans to expand its capacity to 1.4 million barrels per day to meet growing fuel needs in the continent and beyond.
Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules
WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
IRS boosts contribution limits for 401(k) retirement plan savers
Americans will be allowed to contribute more of their money to 401(k) and similar retirement saving plans next year.
Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending
Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
Why Is Phio Pharmaceuticals Stock Soaring Today?
Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.
Consumer Tech News (Oct 27-31): Nvidia Surpasses $5T Market Cap, Trump-Xi Meeting Concludes, Big Tech Report Earnings & More
Apple, Amazon, Microsoft, and Alphabet beat Q3 estimates with revenue and earnings growth. Trump and Xi conclude high-stakes meeting with trade, soybean, and resource agreements, potentially impacting U.S.-China economic relations and global markets.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
Some Head Start preschools shutter as government shutdown continues
The government shutdown is triggering a wave of closures of , leaving working parents scrambling for child care and shutting some of the nation's neediest children out of preschool.
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
Ford's enormous F-150 becomes unlikely part of Japan's efforts to woo Trump
TOKYO (AP) — Japan's most iconic truck might be the tiny white transport vehicles that farmers use to lug gear on the narrow roads that link their rice fields.
Trump Hits Sherrill, Boosts Ciattarelli In New Jersey
Donald Trump attacks Mikie Sherrill in NJ telerally, backs Jack Ciattarelli, sparking energy policy clashes and sharp campaign rebuttals statewide.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Instacart Powers Grubhub's Grocery Blitz Across America
Grubhub taps Instacart for nationwide grocery ordering, with Instacart fulfillment, pharmacy additions coming, and promos boosting adoption despite CART dip.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.